High-fat diet-induced obesity exacerbates kainic acid-induced hippocampal cell death
© Kang et al. 2015
Received: 2 June 2015
Accepted: 29 September 2015
Published: 30 October 2015
Obesity has deleterious effects on the brain, and metabolic dysfunction may exacerbate the outcomes of seizures and brain injuries. However, it is unclear whether obesity affects excitotoxicity-induced neuronal cell death. The purpose of this study was to investigate the effects of a high-fat diet (HFD) on neuroinflammation and oxidative stress in the hippocampus of kainic acid (KA)-treated mice.
Mice were fed with a HFD or normal diet for 8 weeks and then received a systemic injection of KA. HFD-fed mice showed hypercholesterolemia, insulin resistance, and hepatic steatosis. HFD-fed mice showed greater susceptibility to KA-induced seizures, an increased number of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells, neuroinflammation, and oxidative stress. Furthermore, we found that KA treatment increased HFD-induced calpain1, nuclear factor E2-related factor 2, and heme oxygenase-1 expression in the hippocampus.
These findings imply that complex mechanisms affected by obesity-induced systemic inflammation, neuroinflammation, ER stress, calcium overload, and oxidative stress may contribute to neuronal death after brain injury.
KeywordsObesity Excitotoxicity Neuroinflammation Oxidative stress Hippocampus
Patients with epilepsy have a greater risk for obesity than the general population due to treatment of anti-epileptic medications [1, 2], and obesity is also a common comorbidity in children with untreated epilepsy [3, 4]. Although metabolic dysfunction is known to modulate the outcome of brain injury and increase seizure severity , it remains unclear the molecular mechanisms that metabolic dysfunction causes excitotoxicity-induced neuronal death. However, accumulating evidence suggests that metabolic dysfunction could have a deleterious effect on excitotoxicity-induced neuronal death. Specifically, a high-fat diet (HFD) is associated with brain insulin resistance and compromised synaptic integrity . Adiponectin-deficient mice exhibit insulin resistance, hyperlipidemia, and inflammation [5, 7], and adiponectin-deficient mice fed a HFD display increased seizure severity, whereas injection of adiponectin reduces kainic acid (KA)-induced excitotoxicity [5, 8]. Furthermore, the neurotoxins methamphetamine and KA increase mortality and neurodegeneration in ob/ob mice more than in lean mice .
KA-induced hippocampal changes are associated with blood-brain barrier (BBB) leakage, astrogliosis, inflammation, oxidative stress, calcium overload, apoptosis, and endoplasmic reticulum (ER) stress [10–13]. Nuclear factor-kappaB (NF-κB)-mediated neuroinflammation is induced by seizures and increases susceptibility to excitotoxicity-induced neuronal cell death . In particular, the nuclear factor E2-related factor 2 (Nrf2)-mediated defense pathway is involved in neuronal sensitivity to KA , and activation of this pathway exerts neuroprotective effects by elevating antioxidant enzymes . For example, Nrf2 plays an important role in protecting hepatocytes from hepatic steatosis in HFD-fed mice . Obesity-induced mitochondrial dysfunction and oxidative stress also contribute to the initiation and progression of seizures . In our previous study, we showed that an ER stress inhibitor attenuates KA-induced hippocampal cell death . However, to our knowledge, whether the Nrf2-mediated antioxidant pathway plays a role in KA-induced brain injury in HFD-fed mice has not been studied.
Therefore, the aim of the present study was to determine whether chronic HFD-induced obesity contributes to deleterious effects of KA treatment on the hippocampus and to investigate several mechanisms including inflammation and oxidative stress between metabolic dysfunction and neuronal injury. We also examined whether obesity-induced systemic inflammation exacerbates the inflammatory changes induced by KA treatment.
Effect of a HFD on obesity-related phenotypes and insulin resistance
Mice were fed with a normal diet (ND) or HFD for 8 weeks. HFD mice had heavier body weights, livers and epididymal fat pads than ND mice (Additional file 1: Fig. S1A–D). H&E staining revealed that HFD mice had distended hepatocytes with accumulated fat and epididymal fat pads with the presence of many macrophages (Additional file 1: Fig. S1E). HFD mice also had higher levels of hepatic triglyceride (TG) than ND mice (Additional file 1: Fig. S1F). To confirm whether a HFD causes metabolic dysfunction, we measured levels of serum lipid metabolic factors and hepatic enzymes. HFD mice displayed elevated levels of serum free fatty acid (FFA), aspartate aminotransferase (AST), alanine aminotransferase (ALT), total cholesterol, and TG (Additional file 2: Table S1).
To confirm the effect of a HFD on insulin resistance, we measured blood glucose and serum insulin level, and performed glucose tolerance test (GTT) and insulin tolerance test (ITT) (Additional file 3: Fig. S2A–D). After 4 weeks, HFD mice were more glucose tolerant than ND mice (Additional file 3: Fig. S2A). HFD mice showed hyperinsulinemia and a greater increase in glucose levels than ND mice during an ITT and a GTT (Additional file 3: Fig. S2B–D). HFD mice also exhibited hypoadiponectinemia (Additional file 3: Fig. S2E) and increased serum levels of interleukin-6 (IL-6) and tumor necrosis factor (TNF)-α compared with ND mice (Additional file 3: Fig. S2F, G).
Effect of a HFD on KA-induced seizure activity and mortality
Effects of a HFD on KA-induced hippocampal cell death
Effects of a HFD on KA-induced neuroinflammation
Effects of a HFD on KA-induced ER stress and Nrf2/HO-1 defense pathway
The ER response involving protein kinase RNA-like ER kinase (PERK) and its downstream activating transcription factor4 (ATF4) are essential for ER stress-induced apoptosis . To examine whether HFD alters expression of ER stress-induced proteins in the hippocampus after KA treatment, we performed western blot analysis. We found that both KA treatment and a HFD increased PERK and ATF4 expression (Additional file 5: Fig. S4A). These results suggest that HFD contributes to KA-induced neuronal death by increasing ER stress signaling, particularly the PERK-ATF4 pathway. In addition, consistent with an increase in ER stress, we found that both KA treatment and a HFD increased 4-hydroxynonenal (4-HNE) expression (Additional file 5: Fig. S4B).
HFD-induced chronic inflammation, mainly elicited by microglia in the brain, exacerbates pathologies by increasing production of reactive oxygen species (ROS) and proinflammatory cytokines. Our findings support previous observations that obesity is associated with seizure susceptibility in children and that metabolic dysfunction, including insulin resistance, hepatic steatosis, and macrophage infiltration in adipose tissue, contributes to neuroinflammation and exacerbates KA-induced neuronal death [1–5]. Interestingly, HFD-induced calpain1 expression was augmented by KA treatment and KA-induced hippocampal cell death was more prominent in HFD-fed mice than in ND-fed mice. Thus, we suggest that metabolic dysfunction-induced inflammation may augment KA-induced calcium overload, neuroinflammation, and oxidative stress and thereby contribute to neuronal cell death.
Metabolic dysfunction, such as dyslipidemia, insulin resistance, and hepatic steatosis, can exacerbate seizure-induced brain injury [7, 23], and conversely the use of common anti-epileptic drugs leads to weight gain and metabolic dysfunction . In particular, a high-fat, low-carbohydrate ketogenic diet (KD), which is sometimes used to treat drug-resistant epilepsy, can lead to hepatic steatosis [18, 25]. In a previous study, KD-fed mice showed lower fasting blood glucose and homeostatic model assessment of insulin resistance (HOMA-IR) levels than mice fed standard chow and HFD-fed mice showed higher glucose and HOMA-IR levels than KD-fed mice . Taken together, these findings suggest that KD as a treatment for drug-resistant epilepsy does not affect insulin resistance but induces hepatic steatosis. Thus, obesity paired with anti-epileptic drugs or a KD may not exacerbate seizure-induced neuronal cell death, but chronic HFD-induced insulin resistance may bring other seizure-related outcomes such as neuroinflammation, ER stress, and ROS.
We found that mice fed a HFD diet for 8 weeks exhibited obesity-related phenotypes and insulin resistance. Then, we tested whether HFD-induced obesity exacerbates seizures. Consistent with evidence that KA-induced neurotoxicity is exaggerated in ob/ob mice , we found that KA-treated HFD mice showed more severe seizures and greater mortality than KA-treated ND mice. Also, adiponectin deficiency, which is characteristic of obesity and diabetes, increases seizure sensitivity and neuronal loss in the KA-treated hippocampus . Although adiponectin deficiency alone without metabolic changes may not be sufficient to enhance seizure sensitivity, there is a strong positive correlation between seizure severity and insulin resistance in HFD mice . We previously found that intracerebroventricular injection of recombinant adiponectin protects against BBB breakdown and neuronal cell death . In the present study, HFD mice had lower serum adiponectin levels than ND mice. These findings indicate that metabolic disturbances may exacerbate seizure-induced neuronal injury.
We found that KA-treated HFD mice exhibited more neuroinflammation than KA-treated ND mice. Specifically, hippocampal levels of the microglia marker iba-1 were elevated in ND + KA mice and even further elevated in HFD + KA mice. A HFD can cause peripheral and central inflammation and the induction of ROS in rodents . We also found that a HFD increased levels of the inflammatory cytokines IL-6 and TNF-α. As a recent study reports that KA treatment disrupts the BBB , we speculate that HFD-induced induction of inflammatory cytokines may exacerbate KA-induced inflammation through a breakdown of the BBB.
Levels of HMGB1 are increased in children with febrile seizures , and increased expression of HMGB1 contributes to the generation and perpetuation of seizures in humans or mouse models of epilepsy . Furthermore, antagonists of HMGB1 can decrease seizure recurrence . Consistent with our previous study showing that KA treatment induces microglial activation through HMGB1 , we found increased HMGB1 and TLR4 expression in the hippocampus of KA-treated mice with or without HFD and then KA-induced microglial activation was augmented by KA treatment. This data indicate that HFD-induced systemic inflammation may exacerbate KA-induced neuroinflammation through microglial activation.
Oxidative stress is an important factor contributing to excitotoxicity-induced brain injury. ROS enhances glutamate release and expression of specific genes of lipid peroxidation and DNA oxidation resulting in neuronal death . In a previous study, valproic acid, which is commonly used to treat epileptic seizures, reduced the number of TUNEL-, iba-1-, and 4-HNE-positive cells in rats with ischemic injury . Consistently, higher levels of 4-HNE were found in the hippocampus of rats with soman-induced seizures , suggesting that increases in lipid peroxidation products might be due to excitotoxicity-induced increases of NO-related reactive radicals in the KA-treated hippocampus. Alternatively, mild oxidative stress induced by a KD may activate an Nrf2-mediated antioxidant response, leading to a decrease in ROS production .
In addition to oxidative stress, KA treatment causes a persistent increase in intracellular Ca2+ and disruption of ER-mediated Ca2+ homeostasis in hippocampal neurons . Our previous study demonstrates that an ER stress inhibitor attenuates KA-induced Ca2+ signaling and activation of the PERK-ATF4 pathway 6 h after KA treatment . In the present study, we found that although both a HFD and KA treatment increased hippocampal levels of PERK and ATF4, their expressions in HFD-treated mice were not significantly increased by KA treatment. This data indicate that chronic HFD itself may contribute to ER stress in the brain.
Nrf2 participates in the modulation of microglia under conditions of lipopolysaccharide- or MPTP-induced neuroinflammation . In the present study, we observed increased levels of Nrf2/HO-1 in the KA-treated hippocampus and even greater levels in the hippocampus of HFD + KA-treated mice. In agreement with our results, a previous study showed higher Nrf2 mRNA levels in the cerebral cortex of HFD mice compared with ND mice . We found that in addition to elevated nuclear Nrf2 content, total Nrf2 was also increased in HFD + KA mice. A previous study reports that Nrf2 knockout mice display increased sensitivity to KA-induced seizures , suggesting that Nrf2 activation is an important defense against the deleterious outcomes of KA treatment. Similar to Nrf2 expression, we found that KA-induced HO-1 and NQO1 expression was further increased by HFD, suggesting that activation of Nrf2/ARE may be a response to the seizure-induced brain damage. Mostly, both HO-1 and NQO1 are considered as representative antioxidant proteins via Nrf2 signaling. Because mouse NQO1 promoter gene contains an Nrf2-binding consensus regulatory sequence known as ARE . A previous study suggests that inhibitor of HO-1 do not improve neuronal survival and increases mortality in KA-injected rats , but pretreatment with the anti-oxidant curcumin attenuates KA-induced neuronal death by controlling HO-1 expression . However, our results suggest that activation of the Nrf2/HO-1/NQO1 pathway may respond to chronic HFD-induced oxidative stress and aggravate brain insults such as ischemia, trauma, and seizures. Thus, we suggest that Nrf2 is involved in regulating the expression of both HO-1 and NQO1 against KA-induced oxidative or inflammatory insults.
In conclusion, the results of this study suggest that complex mechanisms affected by obesity-induced systemic inflammation, neuroinflammation, ER stress, calcium overload, and oxidative stress may contribute to neuronal death after brain injury.
Male ICR mice (5 weeks old) were purchased from KOATECH Co. (Pyeongtaek, South Korea) and maintained in the animal facility at Gyeongsang National University. All animal experiments were approved by the institutional review board at Gyeongsang National University and were performed in accordance with the National Institutes of Health guidelines for laboratory animal care. Mice were individually housed with a 12-h light/dark cycle and had free access to food pellets and tap water.
HFD and seizure induction
Mice were fed with either a normal laboratory chow diet (ND, 2018S; 18 kcal % fat, 58 kcal % carbohydrate, and 24 kcal % protein, Harlan Laboratories, Inc., Indianapolis, IN, USA) or a HFD (D12079B; 60 kcal % fat, 20 kcal % carbohydrate, and 20 kcal % protein, Research Diets, New Brunswick, NJ, USA) ad libitum for 8 weeks and then received an intraperitoneal injection of 30 mg/kg KA (Abcam, Cambridge, MA, USA) emulsified in 0.9 % normal saline. Mice were divided randomly into four groups: ND (n = 14), HFD (n = 14), ND and KA injection (ND + KA, n = 20), or HFD and KA injection (HFD + KA, n = 20). Mice were monitored for seizure behavior for 2 h after KA injection. Seizure severity was assessed by a 6-point scale (I–VI) as previously described .
For EEG recordings of KA-induced seizures, we used a small animal radio telemetry system (Data Sciences International, St. Paul, MN, USA) to monitor brain electrical activity in freely mobile ND + KA or HFD + KA mice. EEG recordings were performed after surgical implantation of telemetric transmitters (TA10EA-F20; Data Sciences International) using procedures adapted from those used in a previous study with similar equipment . Prior to surgery, mice were anesthetized with zoletil (0.5 mg/kg, Virbac Laboratories, Carros, France). EEG activity was monitored for 6 h as previously described . To distinguish between abnormal interictal spikes and physiologically occurring spikes in epidural one-channel EEG, we manually counted only spikes that were followed by a wave.
GTT and ITT
For the GTT, mice were fasted overnight (16 h) and then received an intraperitoneal injection of d-glucose (2 g/kg; Sigma-Aldrich, St. Louis, MO, USA). Blood samples were then collected from the tail vein. For the ITT, mice were given a intraperitoneal injection of insulin (0.75 U/kg, Humulin-R; Eli Lilly, Indianapolis, IN, USA), and blood glucose was measured using an Accu-Chek glucometer (Roche Diagnostics GmbH, Mannheim, Germany).
Tissue preparation and staining
For tissue analysis, mice were anesthetized with zoletil (5 mg/kg, Virbac Laboratories) and then perfused transcardially with heparinized saline followed by 4 % paraformaldehyde in 0.1 M phosphate-buffered saline (PBS). After post-fixation in the same fixative for 6 h, brains were sequentially immersed in PBS containing 15 % and then 30 % sucrose at 4 °C until they were completely submerged. Brains were cut into 40-μm thick coronal sections and stained with cresyl violet. Livers and epididymal fat pads were processed for paraffin embedding, sectioned (5 µm), and stained with hematoxylin and eosin (H&E). Sections were visualized under a BX51 light microscope (Olympus, Tokyo, Japan), and digital images were captured.
Hepatic TG colorimetric assay
Frozen livers were freshly homogenized, and the supernatants were used to determine TG levels. TG concentration (n = 6 mice per group) was measured using a TG colorimetric assay kit (Cayman Chemical Company, Ann Arbor, MI, USA).
Measurement of serum metabolic parameters
Mice were intramuscularly anesthetized with zoletil (5 mg/kg; Virbac Laboratories), and blood samples were extracted transcardially and allowed to clot for 2 h at room temperature. After centrifugation, serum samples were stored at −80 °C until analysis. Serum AST, ALT, FFA, total cholesterol, and TG levels were determined using enzymatic colorimetric assays (Green Cross Reference Laboratory, Yongin-si, South Korea). Serum insulin and adiponectin concentrations in ND and HFD mice (n = 8–10 mice per group) were measured using mouse insulin (Shibayagi Co., Gunma, Japan) and adiponectin (Shibayagi) enzyme-linked immunosorbent assay (ELISA) kits, respectively. Serum IL-6 and TNF-α concentrations (n = 8–10 mice per group) were measured using mouse IL-6 and TNF-α ELISA kits (R&D Systems, MN, USA), respectively.
TUNEL analysis was performed to measure the degree of apoptosis in tissue using an in situ cell death detection kit (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer’s protocol. Stained brain sections were visualized with a confocal microscope (FV-1000, Olympus), and digital images were captured. For each treatment group, TUNEL-positive cells were manually counted in the CA3 region (50 × 50 µm) in three sections (n = 3 mice per group). The cells were counted by observers blinded to the treatment conditions using 20× objectives.
For double immunofluorescence staining, frozen free-floating brain sections were incubated with primary antibodies (Additional file 6: Table S2); rabbit anti-hippocalcin, mouse anti-NeuN, rabbit anti-Nrf2 at 4 °C for 2 days. After washing three times with PBS, sections were incubated with Alexa Fluor 488- or 594-conjugated donkey anti-rabbit or anti-mouse antibody (Invitrogen, Carlsbad, CA, USA). Fluorescence was visualized with a confocal microscope (FV-1000, Olympus), and digital images were captured.
Frozen free-floating brain sections were incubated with rabbit anti-COX-2 (Additional file 6: Table S2) overnight at 4 °C. After three washes with PBS, sections were incubated for 1 h at room temperature with biotinylated secondary antibody. After washing three times with PBS, sections were incubated in avidin–biotin-peroxidase complex solution (Vector Laboratories, Burlingame, CA, USA). Sections were developed with 0.025 % diaminobenzidine (Sigma) containing 0.025 % H2O2, mounted on gelatin-coated slides, warm-dried, dehydrated through graded alcohols, cleared in xylene, and finally coverslipped with Permount (Sigma). Stained sections were visualized with a BX51 light microscope (Olympus), and digital images were captured.
Western blot analysis
After anesthesia with zoletil (5 mg/kg; Virbac Laboratories), brains were quickly removed from skulls, and both hippocampi were dissected and frozen. Hippocampal whole cellular extracts and nuclear fractions were prepared as previously described . Frozen hippocampi were individually transferred to sterile 1.5-ml microcentrifuge tubes containing 200 µl lysis buffer (15 mM HEPES, pH 7.9, 0.25 M sucrose, 60 mM KCl, 10 mM NaCl, 1 mM EGTA, 1 mM PMSF, and 2 mM NaF). Homogenized tissue was incubated for 10 min on ice and then sonicated. Samples were then centrifuged at 4 °C for 30 min at 12,000 rpm. The supernatants were transferred to clean vials and stored at −80 °C. The protein concentration of each lysate was determined using a bicinchoninic acid kit (Pierce, Rockford, IL, USA) according to the manufacturer’s protocol, using bovine serum albumin as a standard. Equal amounts of protein (30 μg) were separated by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were washed in Tris-buffered saline containing 0.5 % Tween-20 and incubated with the following primary antibodies (Additional file 6: Table S2): iba-1, HMGB1, TLR4, 4-HNE, PERK, ATF4, HO-1, NQO1, COX-2, or iNOS. Samples were then incubated with their corresponding secondary antibodies. The enhanced chemiluminescence western blot analysis system (Amersham Pharmacia Biotech, Piscataway, NJ, USA) was used for detection. To normalize protein levels, α-tubulin or β-actin was used as an internal control.
Differences among experimental groups were determined using one-way analysis of variance (ANOVA) followed by post hoc analysis with Student–Newman–Keuls tests. Student’s t-tests were used for comparisons between two groups. Values are expressed as mean ± standard error of the mean (SEM). Statistical significance was set at p < 0.05.
activating transcription factor 4
C/EBP homology protein
eukaryotic translation initiation factor 2α
free fatty acid
glucose tolerance test
high mobility group box 1
homeostasis model assessment-estimated insulin resistance
inducible nitric oxide synthase
insulin tolerance test
nuclear factor erythroid 2-related factor 2
ER response involving protein kinase RNA-like ER kinase
toll-like receptor 4
terminal deoxynucleotidyl transferase dUTP nick end labeling
tumor necrosis factor-α
GSR initiated the project; DHK, RWH, CY, and HK performed experiments; DHK, RWH, and CY participated in the experimental analyses; DHK, CHC, and GSR discussed the interpretation of animal study; CHC and GSR supervised the study; DHK and GSR wrote the manuscript. All authors read and approved the final manuscript.
This study was supported by a Grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111436) and the Basic Science Research Program through the National Research Foundation (NRF) of Korea (Nos. 2014-0420, 2014R1A2A1A11049588 and 2015R1A5A2008833). No potential conflicts of interest relevant to this article were reported.
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Janousek J, Barber A, Goldman L, Klein P. Obesity in adults with epilepsy. Epilepsy Behav. 2013;28:391–4.View ArticlePubMedGoogle Scholar
- Verrotti A, D’Egidio C, Mohn A, Coppola G, Chiarelli F. Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications. Obes Rev. 2011;12:e32–43.View ArticlePubMedGoogle Scholar
- Daniels ZS, Nick TG, Liu C, Cassedy A, Glauser TA. Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy. Neurology. 2009;73:658–64.View ArticlePubMedPubMed CentralGoogle Scholar
- Ladino LD, Hernández-Ronquillo L, Téllez-Zenteno JF. Obesity and its association with generalised epilepsy, idiopathic syndrome, and family history of epilepsy. Epileptic Disord. 2014;16:343–53.PubMedGoogle Scholar
- Lee EB, Warmann G, Dhir R, Ahima RS. Metabolic dysfunction associated with adiponectin deficiency enhances kainic acid-induced seizure severity. J Neurosci. 2011;31:14361–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, et al. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis. 2014;67:79–87.View ArticlePubMedPubMed CentralGoogle Scholar
- Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731–7.View ArticlePubMedGoogle Scholar
- Jeon BT, Shin HJ, Kim JB, Kim YK, Lee DH, Kim KH, et al. Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity. Brain Res Rev. 2009;61:81–8.View ArticlePubMedGoogle Scholar
- Sriram K, Benkovic SA, Miller DB, O’Callaghan JP. Obesity exacerbates chemically induced neurodegeneration. Neuroscience. 2002;115:1335–46.View ArticlePubMedGoogle Scholar
- Shin HJ, Lee JY, Son E, Lee DH, Kim HJ, Kang SS, et al. Curcumin attenuates the kainic acid-induced hippocampal cell death in the mice. Neurosci Lett. 2007;416:49–54.View ArticlePubMedGoogle Scholar
- Lee JY, Jeon BT, Shin HJ, Lee DH, Han JY, Kim HJ, et al. Temporal expression of AMP-activated protein kinase activation during the kainic acid-induced hippocampal cell death. J Neural Transm. 2009;116:33–40.View ArticlePubMedGoogle Scholar
- Kim YS, Choi MY, Ryu JH, Lee DH, Jeon BT, Roh GS, et al. Clusterin interaction with Bcl-xL is associated with seizure-induced neuronal death. Epilepsy Res. 2012;99:240–51.View ArticlePubMedGoogle Scholar
- Kim JS, Heo RW, Kim H, Yi CO, Shin HJ, Han JW, Roh GS. Salubrinal, ER stress inhibitor, attenuates kainic acid-induced hippocampal cell death. J Neural Transm. 2014;121:1233–43.View ArticlePubMedGoogle Scholar
- Shin HJ, Kim H, Heo RW, Kim HJ, Choi WS, Kwon HM, Roh GS. Tonicity-responsive enhancer binding protein haplodeficiency attenuates seizure severity and NF-κB-mediated neuroinflammation in kainic acid-induced seizures. Cell Death Differ. 2014;21:1095–106.View ArticlePubMedPubMed CentralGoogle Scholar
- Kraft AD, Lee JM, Johnson DA, Kan YW, Johnson JA. Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J Neurochem. 2006;98:1852–65.View ArticlePubMedGoogle Scholar
- Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236:313–22.View ArticlePubMedGoogle Scholar
- Xu W, Shao L, Zhou C, Wang H, Guo J. Upregulation of Nrf2 expression in non-alcoholic fatty liver and steatohepatitis. Hepatogastroenterology. 2011;58:2077–80.PubMedGoogle Scholar
- Balosso S, Liu J, Bianchi ME, Vezzani A. Disulfide-containing high mobility group box-1 promotes N-methyl-d-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid Redox Signal. 2014;21:1726–40.View ArticlePubMedGoogle Scholar
- Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010;16:413–9.View ArticlePubMedGoogle Scholar
- Galehdar Z, Swan P, Fuerth B, Callaghan SM, Park DS, Cregan SP. Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J Neurosci. 2010;30:16938–48.View ArticlePubMedGoogle Scholar
- Ding Y, Chen M, Wang M, Wang M, Zhang T, Park J, et al. Neuroprotection by acetyl-11-keto-β-Boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathway. Sci Rep. 2014;4:7002.View ArticlePubMedPubMed CentralGoogle Scholar
- Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116.View ArticlePubMedGoogle Scholar
- Erbayat-Altay E, Yamada KA, Wong M, Thio LL. Increased severity of pentylenetetrazol induced seizures in leptin deficient ob/ob mice. Neurosci Lett. 2008;433:82–6.View ArticlePubMedGoogle Scholar
- Aydin K, Serdaroglu A, Okuyaz C, Bideci A, Gucuyener K. Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate. J Child Neurol. 2005;20:848–51.View ArticlePubMedGoogle Scholar
- Freeman JM, Vining EP. Ketogenic diet: a time-tested, effective, and safe method for treatment of intractable childhood epilepsy. Epilepsia. 1998;39:450–1.View ArticlePubMedGoogle Scholar
- Selfridge JE, Wilkins HM, Lezi E, Carl SM, Koppel S, Funk E, et al. Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. J Bioenerg Biomembr. 2015;47:1–11 (Epub ahead of print).View ArticlePubMedGoogle Scholar
- Pipatpiboon N, Pintana H, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Eur J Neurosci. 2013;37:839–49.View ArticlePubMedGoogle Scholar
- Choi J, Min HJ, Shin JS. Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J Neuroinflammation. 2011;8:135.View ArticlePubMedPubMed CentralGoogle Scholar
- Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun. 2011;25(7):1281–9.View ArticlePubMedGoogle Scholar
- Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab. 2001;21:2–14.View ArticlePubMedGoogle Scholar
- Suda S, Katsura K, Kanamaru T, Saito M, Katayama Y. Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation. Eur J Pharmacol. 2013;707:26–31.View ArticlePubMedGoogle Scholar
- Jacobsson SO, Cassel GE, Persson SA. Increased levels of nitrogen oxides and lipid peroxidation in the rat brain after soman-induced seizures. Arch Toxicol. 1999;73:269–73.View ArticlePubMedGoogle Scholar
- Milder J, Patel M. Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Res. 2012;100:295–303.View ArticlePubMedGoogle Scholar
- Paschen W, Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium. 2005;38:409–15.View ArticlePubMedGoogle Scholar
- Innamorato NG, Rojo AI, García-Yagüe AJ, Yamamoto M, de Ceballos ML, Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol. 2008;181:680–9.View ArticlePubMedGoogle Scholar
- Petri S, Körner S, Kiaei M. Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int. 2012;2012:878030.View ArticlePubMedPubMed CentralGoogle Scholar
- Huang E, Ong WY, Go ML, Garey LJ. Heme oxygenase-1 activity after excitotoxic injury: immunohistochemical localization of bilirubin in neurons and astrocytes and deleterious effects of heme oxygenase inhibition on neuronal survival after kainate treatment. J Neurosci Res. 2005;80:268–78.View ArticlePubMedGoogle Scholar
- Jeong EA, Jeon BT, Shin HJ, Kim N, Lee DH, Kim HJ, et al. Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures. Exp Neurol. 2011;232:195–202.View ArticlePubMedGoogle Scholar
- Claycomb RJ, Hewett SJ, Hewett JA. Neuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2. Neurobiol Dis. 2012;45:234–42.View ArticlePubMedGoogle Scholar